Gabriela Luchiari Tumioto Giannini

Gabriela Luchiari Tumioto Giannini

Auto-generated profile, based on publicly available information

Gabriela Luchiari Tumioto Giannini

Hospital Moinhos de Vento

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2021 in medRxiv
Verified
Preprint
Open access
PDF file
MPMárcia Polese-Bonatto
Márcia Polese-Bonatto
ISIvaine Tais Sauthier Sartor
Ivaine Tais Sauthier Sartor
FVFernanda Hammes Varela
Fernanda Hammes Varela
GGGabriela Luchiari Tumioto Gianinni
Gabriela Luchiari Tumioto Gianinni
TAThaís Raupp Azevedo
Thaís Raupp Azevedo
RSRenato T. Stein
Renato T. Stein
Background The viral dynamics and the role of children in the spread of SARS-CoV-2 are not completely understood. Our aim was to evaluate how RT-PCR Ct values among children with confirmed SARS-CoV-2 compared with that of adult subjects. Methods Patients (aged from 2 months to ≤18 years, and adults) with signs and symptoms of acute SARS-CoV-2 infection for less than 7 days, were prospectively enrolled in the study from May to November 2020. All participants performed RT-PCR assay for SARS-CoV-2 detection; Ct values of ORF1ab, N, and S gene-targets, and the average of all the three probes were used as surrogates of viral load. Results Of the total of 376 participants with confirmed SARS-CoV-2 infection there were 21 infants, 62 children and 293 adults. The RT-PCR Ct values of children under 18 were not significantly different from that of adults, as observed by the analyzed probes (namely ORF1ab, N, and S), and by the mean of all 3 gene-targets. However, infants had significantly lower Ct values compared to children and adults (P = 0.044). Discussion Ct values for children were not significantly different than that of adults with positive SARS-CoV-2. Interestingly, infants had even lower Ct values when compared to older children and adults. Although viral load is not the only determinant of transmission, infants may play a significant role in the spread of SARS-CoV-2 in the community, especially if or when this population returns to regular daycare activities.

10 February 2022 in The Brazilian Journal of Infectious Diseases
Verified
Journal Article
Open access
TAThaís Raupp Azevedo
Thaís Raupp Azevedo
LKLuciane Beatriz Kern
Luciane Beatriz Kern
MPMárcia Polese-Bonatto
Márcia Polese-Bonatto
ISIvaine Tais Sauthier Sartor
Ivaine Tais Sauthier Sartor
FVFernanda Hammes Varela
Fernanda Hammes Varela
MSMarcelo Comerlato Scotta
Marcelo Comerlato Scotta
Apesar do predomínio do SARS-CoV-2 como etiologia das infecções virais em adultos durante o ano de 2020, outros agentes infecciosos podem fazer parte do diagnóstico diferencial. O objetivo deste estudo foi descrever a prevalência dos patógenos respiratórios em adultos internados em dois hospitais no sul do Brasil durante a pandemia e comparar os desfechos de gravidade na internação entre participantes com diagnóstico de COVID-19 comparado com outros agentes infecciosos. Participantes adultos (> 18 anos) hospitalizados com sinais agudos de tosse, febre ou dor de garganta foram recrutados prospectivamente entre maio e novembro de 2020, e seguidos até o final da internação. A técnica de RT-PCR foi utilizada para detecção de SARS-CoV-2 e demais agentes infecciosos. Para SARS-CoV-2 foram coletados swabs oro e nasofaríngeo bilateral tendo como alvos os genes S, N e ORF1ab. Outro swab nasofaríngeo foi coletado para realização de painel respiratório através sondas de expressão gênica que avaliou a presença de: Bordetella pertussis; Chlamydophila pneumoniae; Mycoplasma pneumoniae; adenovírus; bocavírus; coronavírus tipos HKU1, 229E, NL63 e OC43; vírus influenza A tipos H1 e H3; vírus influenza B; enterovírus; metapneumovírus; vírus parainfluenza tipos 1, 2 e 3; RSV tipos A e B; e rinovírus. Todas as amostras foram analisadas no Laboratório de Biologia Molecular do Hospital Moinhos de Vento. Foram incluídos 156 participantes, sendo a maioria homens (57,1%) com idade mediana de 58 anos. A mediana de dias de sintomas foi 8 dias. O SARS-CoV-2 foi o agente mais prevalente, sendo detectado exclusivamente em 101 (65.0%) de 156 participantes, seguido pela detecção única de rinovírus (4,0%, 6/154). A codetecção desses dois agentes ocorreu em 28 (18,0%) dos 154 participantes. Os demais patógenos (adenovírus, coronavírus HKU1 e enterovírus) foram detectados em 5 participantes. A comparação dos desfechos de gravidade (uso de oxigênio suplementar, ventilação mecânica invasiva e óbito) não apresentou diferença quanto à codetecção versus detecção exclusiva de SARS-CoV-2 (60,7% (17/28) vs 62,4% (63/101), P = 1,00; 21,4% (6/28) vs 15,8% (16/101), P = 0,57; 7,1% (2/28) vs 5,9% (6/101), P = 0,68). O SARS-CoV-2 foi o principal patógeno detectado seguido pelo rinovírus, com uma importante queda na detecção de outros patógenos. A detecção de rinovírus simultânea ao SARS-CoV-2 não foi associada a maior gravidade.

7 October 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
FSFernando Hayashi Sant'Anna
Fernando Hayashi Sant'Anna
TATiago Finger Andreis
Tiago Finger Andreis
RSRichard Salvato
Richard Salvato
AMAna Paula Muterle
Ana Paula Muterle
JCJuliana Comerlato
Juliana Comerlato
EWEliana Wendland
Eliana Wendland
With the coexistence of multiple lineages and increased international travel, recombination and gene flow are likely to become increasingly important in the adaptive evolution of SARS-CoV-2. This could result in the incipient parallel evolution of multiple recombinant lineages. However, identifying recombinant lineages is challenging, and the true extent of recombinant evolution in SARS-CoV-2 may be underestimated. This study describes the first SARS-CoV-2 Deltacron recombinant case identified in Brazil. We demonstrate that the recombination breakpoint is at the beginning of Spike gene ( S ). The 5′ genome portion (circa 22 kb) resembles the AY.101 lineage (VOC Delta), and the 3′ genome portion (circa 8 kb nucleotides) is most similar to the BA.1.1 lineage (VOC Omicron). Furthermore, evolutionary genomic analyses indicate that the new strain emerged after a single recombination event between lineages of diverse geographical locations in December 2021 in South Brazil. This Deltacron, named AYBA-RS, is one out of almost 30 recombinants described this year. The submission of only four sequences in the GISAID database suggests that this Brazilian lineage had a minor epidemiological impact. On the other hand, the recent emergence of this and various other Deltacron recombinant lineages (i.e., XD, XF, and XS) suggests that gene flow and recombination may play an increasingly important role in the COVID-19 pandemic. We explain the evolutionary and population genetic theory that support this assertion, and we conclude that this stresses the need for continued genomic and epidemiological surveillance. This is particularly important for countries where multiple variants are present, as well as for countries that receive significant inbound international travel.

14 September 2021 in medRxiv
Verified
Preprint
Open access
PDF file
ISIvaine Tais Sauthier Sartor
Ivaine Tais Sauthier Sartor
FVFernanda Hammes Varela
Fernanda Hammes Varela
MMMariana Rost MEIRELES
Mariana Rost MEIRELES
LKLuciane Beatriz Kern
Luciane Beatriz Kern
TAThaís Raupp Azevedo
Thaís Raupp Azevedo
CGCOVIDa study group
COVIDa study group
Background: The emergence of SARS-CoV-2 variants is a current public health concern possibly impacting COVID-19 disease diagnosis, transmission patterns and vaccine effectiveness. Objectives: To describe the SARS-CoV-2 lineages circulating early pandemic among samples with S gene dropout and characterize a novel mutation in receptor-binding domain (RBD) of viral spike protein. Study design: Adults and children older than 2 months with signs and symptoms of COVID-19 were prospectively enrolled from May to October 2020 in Porto Alegre, Brazil. All participants performed RT-PCR assays for diagnosing SARS-CoV-2, samples with S gene dropout and Ct < 30 (cycle threshold) were submitted to whole genome sequencing (WGS), and homology modeling and physicochemical properties analysis were performed. Results: 484/1,557 participants tested positive for SARS-CoV-2. The S gene dropout was detected in 7.4% (36/484) as early as May, and a peak was observed in early August. WGS was performed in 8 samples. The B.1.1.28, B.1.91 and B.1.1.33 lineages were circulating in early pandemic. The RBD novel mutation (Y380Q) was found in one sample occurring simultaneously with C379W and V395A, and the B.1.91 lineage in the spike protein. Conclusion: Mutations in the SARS-CoV-2 spike region were detected early in the COVID-19 pandemic in Southern Brazil, regarding the B.1.1.28, B.1.91 and B.1.1.33 lineages identified. The novel mutation (Y380Q) with C379W, modifies important RBD properties, which may interfere with the binding of neutralizing antibodies (CR3022, EY6A, H014, S304). Highlights: Characterization of novel mutation (Y380Q) in RBD of SARS-CoV-2 spike protein The Y380Q and C379W modify important properties in the SARS-CoV-2 RBD region The RBD mutations may interfere with the binding of neutralizing antibodies The B.1.1.28, B.1.91 and B.1.1.33 lineages were circulating in early pandemic